Back to results
US 2015/0175703 A1Published application
Extended treatment of multiple sclerosis
AssigneeBiogen Idec MA Inc.
InventorsMichael Panzara, Frances Lynn, Martin Toal
Life of this patent
Estimating the term…
Abstract
Methods for extended treatment of multiple sclerosis are described.
Claims17
A method of treating a subject having multiple sclerosis (MS), the method comprising administering, to the subject, a therapeutically effective amount of a VLA-4 binding antibody for at least 24 months.
A method of treating a subject having MS, the method comprising:
- selecting a patient who has received at least 22 doses of a VLA-4 binding antibody over a period of 24 months;
- and
- administering to the patient at least one course of VLA-4 binding antibody therapy sufficient to provide an improved therapeutic effect compared to before commencement of VLA-4 binding antibody therapy.
Dependencies are inferred from the claim text.